Disculpa, pero esta entrada está disponible sólo en English.
(English) The contract manufacturing market for live biotherapeutics and microbiome products is estimated to be worth USD 300 million by 2030, growing at a CAGR of 46%, claims Roots Analysis
(English)
LONDON, Aug. 4, 2020 /PRNewswire/ — Roots Analysis has announced the addition of «Live Biotherapeutic Products and Microbiome Contract Manufacturing Market, 2020-2030: Focus on Active Pharmaceutical Ingredients and Finished Dosage Forms, 2020-2030« report to its list of…
